96961 ⎘
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans; Cytokines; Lymphokines; Interferons; Interleukins [IL] IL-4
ENGINEERED IMMUNOCYTOKINES, FUSION POLYPEPTIDES, AND IL10 POLYPEPTIDES
#2FUSION PROTEIN COMPRISING IL13
#3REGULATION OF IMMUNE RESPONSES THROUGH SELECTIVE NEURAL ACTIVATION
#4MEMBRANE-ANCHORED CYTOKINES, ENGINEERED IMMUNE CELLS, AND USES THEREOF
#5THERAPEUTIC CYTOKINES AND METHODS
#6mRNA VACCINES COMPRISING IL-4 AND/OR IL-13 RNA AND USES THEREOF
#7HIGHLY EFFECTIVE ADOPTIVE T CELL THERAPY
#8COMPOSITIONS COMPRISING AN INTERLEUKIN CONSTRUCT
#9TGF-Beta Polypeptides
#10Split interleukin mimetics and their use
#11DE NOVO DESIGN OF POTENT AND SELECTIVE INTERLEUKIN MIMETICS
#12DUAL CYTOKINE FUSION PROTEINS COMPRISING IL-10
#13COMPOSITIONS AND METHODS FOR TREATING FIBROSIS
#14IL-4 DERIVED PEPTIDES FOR USE IN THE TREATMENT OF OBESITY
#15Dendritic Cell Generator
#16ALTERING CYTOKINE SPECIFICITY THROUGH BINDING VALENCY
#17METHOD OF REDUCING BISPECIFIC T CELL ENGAGER OR CHIMERIC ANTIGEN RECEPTOR T CELL MEDIATED CYTOKINE RELEASE SYNDROME USING INTERLEUKINS-4, -10, OR A FUSION PROTEIN THEREOF
#18METHODS FOR THE PRODUCTION OF THERAPEUTIC, DIAGNOSTIC, OR RESEARCH ANTIBODIES
#19APOLIPOPROTEIN FUSION PROTEINS FOR CELL-SPECIFIC IMMUNE REGULATION
#20IMMUNOREGULATORY METHOD, NUCLEIC ACID COMPOSITION FOR IMMUNOREGULATION, AND USE THEREOF
#21PRECURSOR PROTEINS AND KIT FOR TARGETED THERAPY
#22ANTIBODIES TARGETING BAFF-R AND USE THEREOF
#23PLATFORM TECHNOLOGY FOR TREATMENT OF INFLAMMATORY, IMMUNOLOGICAL AND/OR AUTOIMMUNOLOGICAL DISEASES
#24DIAGNOSTIC DEVICE FOR LOCAL INTRAVENOUS BIOMARKER MEASUREMENTS AND METHODS OF USE THEREOF
#25BISPECIFIC BINDING AGENT-LIGAND FUSIONS FOR THE DEGRADATION OF TARGET PROTEINS
#26PLATFORM TECHNOLOGY FOR TREATMENT OF INFLAMMATORY, IMMUNOLOGICAL AND/OR AUTOIMMUNOLOGICAL DISEASES
#27COMPOSITIONS AND METHODS FOR MODULATING EXPRESSION OF GENES
#28COMPOSITIONS AND METHODS FOR MODULATING EXPRESSION OF GENES
#29Cancer Treatment
#30De novo design of potent and selective interleukin mimetics
#31Dual cytokine fusion proteins comprising IL-10
#32Dual cytokine fusion proteins comprising IL-10
#33Dual cytokine fusion proteins comprising IL-10
#34Dual cytokine fusion proteins comprising IL-10
#35Dual cytokine fusion proteins comprising IL-10
#36REGULATION OF IMMUNE RESPONSES THROUGH SELECTIVE NEURAL ACTIVATION
#37Dual cytokine fusion proteins comprising IL-10
#38Dual cytokine fusion proteins comprising IL-10
#39Dual cytokine fusion proteins comprising IL-10
#40Dual cytokine fusion proteins comprising IL-10
#41Dual cytokine fusion proteins comprising IL-10
#42HYDROGELS CONTAINING AFFIBODIES AND USES THEREOF
#43TGF-Beta Polypeptides
#44VIRUSES ENGINEERED TO PROMOTE THANOTRANSMISSION AND THEIR USE IN TREATING CANCER
#45METHOD OF REDUCING BISPECIFIC T CELL ENGAGER OR CHIMERIC ANTIGEN RECEPTOR T CELL MEDIATED CYTOKINE RELEASE SYNDROME USING INTERLEUKINS-4, -10, OR A FUSION PROTEIN THEREOF
#46IL-10 MUTEINS
#47ANTIGEN-PRESENTING EXTRACELLULAR VESICLES, COMPOSITION CONTAINING SAME, AND METHOD FOR PRODUCTION THEREOF
#48IMMUNOREGULATORY METHOD, NUCLEIC ACID COMPOSITION FOR IMMUNOREGULATION AND USE THEREOF
#49Dendritic cell generator
#50ANAPLASTIC LYMPHOMA KINASE CHIMERIC ANTIGEN RECEPTORS AND METHODS OF USE
#51MODULATING GAMMA-C-CYTOKINE ACTIVITY
#52Humanized IL-4 and IL-4Rα animals
#53METHODS OF SYNTHESIZING MRNA AND FUNCTIONAL PROTEINS FROM SYNTHETIC DOUBLE STRANDED DNA
#54Compositions and Methods for Simultaneously Modulating Expression of Genes
#55Dual cytokine fusion proteins comprising IL-10
#56Dual cytokine fusion proteins comprising IL-10
#57Interleukin-4 Receptor-Binding Fusion Proteins and Uses Thereof
#58TGF-β polypeptides
#59IL-4R AS A BIOMARKER IN CANCER
#60Dual cytokine fusion proteins comprising IL-10
#61T CELL RECEPTORS AND METHODS OF USE THEREOF
#62Dual cytokine fusion proteins comprising IL-10
#63T CELL RECEPTORS AND METHODS OF USE THEREOF
#64Dual cytokine fusion proteins comprising IL-10
#65Dual cytokine fusion proteins comprising IL-10
#66Dual cytokine fusion proteins comprising IL-10
#67NOVEL IL-10 VARIANT PROTEIN AND USE THEREOF
#68De novo design of potent and selective interleukin mimetics
#69FUSION PROTEIN COMPRISING IL13
#70CYTOKINE COCKTAILS FOR SELECTIVE EXPANSION OF T CELL SUBSETS
#71De novo design of potent and selective interleukin mimetics
#72INTERLEUKIN-4 RECEPTOR-BINDING FUSION PROTEINS AND USES THEREOF
#73Methods and reagents for modulating macrophage phenotype
#74Interleukin 21 protein (IL21) mutant and encoding nucleic acid
#75Split interleukin mimetics and their use
#76Dual cytokine fusion proteins comprising IL-10
#77GENERATING HPV ANTIGEN-SPECIFIC T CELLS FROM A NAÏVE T CELL POPULATION
#78Humanized IL-4 and IL-4Rα animals
#79Methods for the production of therapeutic, diagnostic, or research antibodies
#80GENERATING VIRUS OR OTHER ANTIGEN-SPECIFIC T CELLS FROM A NAÏVE T CELL POPULATION
#81GM-CSF and IL-4 Conjugates, Compositions, and Methods Related Thereto
#82COMPOSITIONS COMPRISING AN INTERLEUKIN CONSTRUCT
#83Fusion protein comprising IL13
#84IL-13/IL-4 SUPERKINES: IMMUNE CELL TARGETING CONSTRUCTS AND METHODS OF USE THEREOF
#85Method of producing Th9 T-cells
#86Fusion protein, preparation method therefor and application thereof in preparing ophthalmic disease treatment, anti-inflammation and anti-tumor medicament
#87METHODS AND COMPOSITIONS FOR TREATING ATOPIC DERMATITIS WITH RECOMBINANT MICROORGANISMS
#88IL-4-fusion formulations for treatment of central nervous system (CNS) tumors
#89Dendritic cell generator
#90Novel IL-4-/IL-13-derived peptide compounds for the treatment or prevention of neurodegenerative or neuroinflammatory diseases
#91De novo design of potent and selective interleukin mimetics
#92De novo design of potent and selective interleukin mimetics
#93Expression of metabolic modulators in tumor microenvironment to improve tumor therapy
#94NOVEL INTERLEUKIN 4 IMMUNOCONJUGATES
#95Cancer treatment
#96Fusion protein comprising IL-4 and IL-10
#97Anti-tumor T cells and their preparation using IL-6
#98Compositions comprising R-Spondin (RSPO) surrogate molecules
#99Humanized IL-4 and IL-4Ra animals
#100Systemic targeting of inflammatory sites and enhanced immunomodulatory function by introducing the chimeric antigen receptor (CAR) into mesenchymal stem cells for inflammatory and autoimmune diseases
#101Methods and reagents for modulating macrophage phenotype
#102CYSTEINE VARIANTS OF INTERLEUKIN-11 AND METHODS OF USE THEREOF
#103Mesenchymal stem cells expressing anti-inflammatory cytokines and methods of use
#104Compositions and methods for treating fibrosis
#105Interleukin-4 receptor-binding fusion proteins and uses thereof
#106Interleukin-4 receptor-binding fusion proteins and uses thereof
#107Polyethylenimine (PEI)-polypeptide conjugates and methods of use thereof
#108Modulating gamma-c-cytokine activity
#109Methods for the production of therapeutic, diagnostic, or research antibodies
#110GM-CSF and IL-4 conjugates, compositions, and methods related thereto
#111Fusion polypeptide in which anti-inflammatory polypeptide and ferritin monomer fragment are bound and pharmaceutical composition for preventing and treating inflammatory diseases, containing same as active ingredient
#112METHODS OF PRODUCING AND PURIFYING MATRIX-BINDING FUSION PROTEINS BY ION-EXCHANGE CHROMATOGRAPHY
#113Altered avian virus for in-ovo inoculation and methods of use thereof
#114Dendritic cell generator
#115Recombinant probiotic bacteria
#116Methods of treatment with a fusion protein comprising IL-4 and IL-10
#117GENERATING VIRUS OR OTHER ANTIGEN-SPECIFIC T CELLS FROM A NAÏVE T CELL POPULATION
#118Superkines and synthekines: repurposed cytokines with new and enhanced signaling activities
#119Humanized IL-4 and IL-4Rα animals
#120Method to increase the number of circulating platelets by administering PEGylated cysteine variants of IL-11
#121Cytokine-based fusion proteins for treatment of immune disorders
#122Humanized IL-4 and IL-4Rα animals
#123Modulators of gamma-C-cytokine activity
#124Fusions of antibodies to CD38 and attenuated interferon alpha
#125GM-CSF and IL-4 conjugates, compositions, and methods related thereto
#126Compositions and methods for treating fibrosis
#127Modulating gamma-C-cytokine activity
#128Compositions of GM-CSF and interleukin fusions for immune modulation and uses related thereto
#129Chimeric virus-like particles incorporating fusion GPI anchored GM-CSF and IL-4 conjugates
#130Stimulation of neonatal immunity against EHV-1
#131Superkines and synthekines: repurposed cytokines with new and enhanced signaling activities
#132Interleukin-4 receptor-binding fusion proteins and uses thereof
#133Process for Generating Synthetic Engineered Recombinant Proteins for Vaccination, Diagnosis and Treatment of Disease
#134Interleukin-4 receptor-binding fusion proteins and uses thereof
#135IL4 CONJUGATED TO ANTIBODIES AGAINST EXTRACELLULAR MATRIX COMPONENTS
#136GM-CSF and IL-4 conjugates, compositions, and methods related thereto
#137Compositions and methods for inhibiting terminal transferase activity
#138Albumin fusion proteins
#139Humanized IL-4 and IL-4Ra animals
#140Humanized IL-4 and IL-4Rα animals
#141PHARMACEUTICAL COMPOSITION FOR CANCER TREATMENT INCLUDING FUSION PROTEIN
#142Albumin fusion proteins
#143Cytokine-based fusion proteins for treatment of immune disorders
#144Modified SAK gene for the production of recombinant proteins
#145FUSION PROTEIN COMPRISING AN INTERLEUKIN 4 AND INTERLEUKIN
#146Fusions of antibodies to CD38 and attenuated interferon alpha
#147DERIVATIVES OF GROWTH HORMONE AND RELATED PROTEINS
#148Protein skeletal module which increases the binding affinity and binding specificity of active polypeptides
#149Gelsolin stimulation of blood samples using gold particles
#150Immunomodulatory methods and systems for treatment and/or prevention of hypertension
#151TARGETING COMPOUNDS
#152Modified SAK gene for the production of recombinant proteins
#153Peptides for active anti-cytokine immunization
#154Cytokine zalpha11 ligand
#155Peptides for active anti-cytokine immunization
#156Albumin fusion proteins
#157MEANS AND METHOD FOR THE TREATMENT OF ANTIBODY DEFICIENCY DISEASES BASED ON IL-21 AND IL-21 VARIANTS
#158IL-4-derived peptides for modulation of the chronic inflammatory response and treatment of autoimmune diseases
#159PHARMACEUTICAL POLYPEPTIDE DRY POWDER AEROSOL FORMULATION AND METHOD OF PREPARATION
#160PHARMACEUTICAL POLYPEPTIDE DRY POWDER AEROSOL FORMULATION AND METHOD OF PREPARATION
#161Pharmaceutical Polypeptide Dry Powder Aerosol Formulation and Method of Preparation
#162Compositions and methods for inhibiting terminal transferase activity
#163Cysteine variants of interferon gamma
#164MODIFIED IL-4 MUTEIN RECEPTOR ANTAGONISTS
#165Peptides for active anti-cytokine immunization
#166Receptor-targeting reagents containing epidermal factor receptor-binding agents and IL-13 receptor-binding agents or IL-4 receptor-binding agents
#167PROCESS FOR THE PURIFICATION OF INTERLEUKIN-4 AND ITS MUTEINS
#168Recombinant production of authentic human proteins using human cell expression systems
#169Albumin fusion proteins
#170Pharmaceutical Polypeptide Dry Powder Aerosol Formulation and Method of Preparation
#171Cytokine zalpha11 ligand antibodies
#172CYTOKINE ZALPHA11 LIGAND ANTIBODIES
#173Feline granulocyte macrophage colony stimulating factor proteins
#174INFLAMMATION-INDUCED ANTI-FLAMMATORY GENE EXPRESSION
#175Cytokine zalpha11 ligand antibodies
#176Peptides for active anti-cytokine immunization
#177Method of treatment of age-related macular degeneration
#178Recombinant VSV For The Treatment of Tumor Cells
#179Cytokine-based fusion proteins for treatment of multiple sclerosis
#180CONJUGATE FOR THE SPECIFIC TARGETING OF ANTICANCER AGENTS TO TUMOR CELLS OR TUMOR VASCULATURE AND PRODUCTION THEREOF
#181PARAMETER SELECTED GM-CSF, IL-3, IL-4, IL-5 AND CHIMERAS THEREOF FOR THERAPEUTIC AND DIAGNOSTIC PURPOSES
#182CANINE AND FELINE IMMUNOREGULATORY PROTEINS, NUCLEIC ACID MOLECULES, AND USES THEREOF
#183Albumin Fusion Proteins
#184Albumin Fusion Proteins
#185Methods and compositions for regulating T cell subsets by modulating transcription factor activity
#186DERIVATIVES OF GROWTH HORMONE AND RELATED PROTEINS
#187Methods for Reducing the Immunogenicity of Cytokines and Removal of Cell Surface Markers
#188Modified IL-4 mutein receptor antagonists
#189Cysteine variants of interferon gamma
#190Ligands and libraries of ligands
#191Peptides for active anti-cytokine immunization
#192Anti-T Cell and Autoantigen Treatment of Autoimmune Disease
#193Cysteine variants of interferon-gamma
#194Albumin fusion proteins
#195Albumin Fusion Proteins
#196Albumin fusion proteins comprising insulin polypeptides
#197IL-21 AS A REGULATOR OF IMMUNOGLOBIN PRODUCTION
#198Albumin Fusion Proteins
#199G-CSF-albumin fusion proteins
#200Albumin fusion proteins
#201Methods of identifying compounds that modulate IL-4 receptor mediated IgE synthesis utilizing a CLLD8 protein
#202Pharmaceutical composition for cancer treatment containing cells that express a membrane cytokine
#203Cancer immunotherapy using autologous tumor cells combined with cells expressing a membrane cytokine
#204Methods for regulating T cell subsets by modulating transcription factor activity
#205Albumin fusion proteins
#206Albumin fusion proteins
#207Conjugate for the specific targeting of anticancer agents to tumor cells or tumor vasculature and production thereof
#208Cytokine zalpha11 ligand fusion proteins
#209Canine IL-5 proteins and fragments thereof
#210CYTOKINE ZALPHA11 LIGAND
#211CYTOKINE ZALPHA11 LIGAND ANTIBODIES
#212CYTOKINE ZALPHA11 LIGAND ANTIBODIES
#213Cytokine zalpha11 ligand fusion proteins
#214Cytokine zalpha11 ligand fusion proteins
#215Method for expanding hematopoietic cells using cytokine zalpha11 ligand
#216Cytokine zalpha11 ligand antibodies and methods of use
#217Methods of using cytokine zalpha11 ligand
#218CYTOKINE ZALPHA11 LIGAND FUSION PROTEINS
#219Cytokine zalpha11 ligand fusion proteins
#220Method of use of cytokine ZALPHA11 ligand
#221CYTOKINE ZALPHA11 LIGAND ANTIBODIES
#222Recombinant herpes simplex virus useful for treating neoplastic disease
#223Cytokine zalpha11 ligand antibodies
#224Methods and compositions for regulating T cell subsets by modulating transcription factor activity
#225Feline granulocyte macrophage colony stimulating factor nucleic acid molecules
#226Methods for treating dermatitis using mutant human IL-4 compositions
#227Albumin fusion proteins
#228Peptides for active anti-cytokine immunization
#229Feline interferon-alpha proteins
#230Albumin fusion proteins
#231Process for the purification of interleukin-4 and its muteins
#232Plant bioreactors
#233Vaccine
#234Cysteine substitution variants of beta interferon
#235COOH-terminally added cysteine variant of the beta interferon
#236IL-21 as a regulator of immunoglobin production
#237IL-4/IL-13 specific polypeptides and therapeutic uses thereof
#238Albumin fusion proteins comprising GLP-1 polypeptides
#239Vaccine
#240Chemically modified cytokines
#241Expression vectors and promoters for heterologous gene expression
#242Methods of identifying compounds that modulate IL-4 receptor mediated IgE synthesis utilizing a CLLD8 protein
#243Cysteine variants of erythropoietin
#244Cysteine variants of erythropoietin
#245Modified IL-4 mutein receptor antagonists
#246Conjugate for the specific targeting of anticancer agents to cancer cells and production thereof
#247Process for renaturation of recombinant, disulfide containing proteins at high protein concentrations in the presence of amines